1-4 of 4
immunoglobulin a
Close
Sort by
Journal Articles

The selection of variable regions affects effector mechanisms of IgA antibodies against CD20

Mitchell Evers, Thies Rösner, Anna Dünkel, J. H. Marco Jansen, Niklas Baumann, Toine ten Broeke, Maaike Nederend, Klara Eichholz, Katja Klausz, Karli Reiding, Denis M. Schewe, Christian Kellner, Matthias Peipp, Jeanette H. W. Leusen, Thomas Valerius
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3807–3820.
https://doi.org/10.1182/bloodadvances.2021004598
Published: 2021
Includes: Supplemental data
Journal Articles

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

Clinical Trials & Observations
Tadeusz Robak, Maciej Kaźmierczak, Isidro Jarque, Vasile Musteata, Jacek Treliński, Nichola Cooper, Peter Kiessling, Ute Massow, Franz Woltering, Rose Snipes, Juan Ke, Grant Langdon, James B. Bussel, Stephen Jolles
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4136–4146.
https://doi.org/10.1182/bloodadvances.2020002003
Published: 2020
Includes: Supplemental data
Journal Articles

Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents

Clinical Trials & Observations
Smith Giri, Scott F. Huntington, Rong Wang, Amer M. Zeidan, Nikolai Podoltsev, Steven D. Gore, Xiaomei Ma, Cary P. Gross, Amy J. Davidoff, Natalia Neparidze
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2245–2253.
https://doi.org/10.1182/bloodadvances.2019001425
Published: 2020
Journal Articles

IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia

Clinical Trials & Observations
Ganchimeg Ishdorj, Erin Streu, Pascal Lambert, Harbhajan S. Dhaliwal, Salaheddin M. Mahmud, Spencer B. Gibson, Versha Banerji, Aaron J. Marshall, James B. Johnston
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2188–2198.
https://doi.org/10.1182/bloodadvances.2018026591
Published: 2019
Includes: Supplemental data